Answers are grounded in this paper and cite their sources.
Case report reveals complete resection and SMARCB1 deletion in an infant with renal malignant rhabdoid tumor, highlighting the essential role of molecular confirmation.
Malignant rhabdoid tumor of the kidney (MRTK) is a rare, highly aggressive renal neoplasm predominantly affecting infants, carrying a poor prognosis. We report a 7-month-old female who presented with a 10-day history of painless gross hematuria. Abdominal imaging revealed a large heterogeneous left renal mass without vascular invasion or distant metastases. Left radical nephrectomy with regional lymphadenectomy achieved complete resection (COG Local Stage II, node-negative). Immunohistochemistry demonstrated complete loss of INI1 expression, and next-generation sequencing confirmed a pathogenic SMARCB1 deletion. This case highlights the diagnostic and therapeutic challenges of MRTK in infancy and highlights the indispensable role of molecular confirmation.
No takes yet. Share an insight, caveat, or question.
AlQahtani et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: